Literature DB >> 22326665

[Steroid-induced myopathy].

Serge Perrot1, Claire Le Jeunne.   

Abstract

Steroid muscle-related involvement is a frequent but often underestimated adverse effect of steroid treatment. Clinical presentation may differentiate two features: the less frequent, represented by acute myopathy, essentially observed in resuscitation, in patients treated with high dosages, and the more frequent feature, insidious, painless, chronic myopathy, characterized by a progressive proximal deficit. Diagnosis is mostly based on the clinic, muscle biopsy should remain exceptional, performed to detect other myopathies, since there are no specific anatomopathological findings. Muscle enzymes are rarely increased, electrophysiological analyses demonstrate unspecific and variable abnormalities. Pathophysiology of steroid-induced myopathy is multifactorial, related to protein metabolism modifications (change of both metabolism and catabolism), cellular transcription, growth factors (IGF-1, myostatine). Treatment is unspecific, mostly based on the prevention that should firstly consider steroid dosage reduction. Copyright Â
© 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326665     DOI: 10.1016/j.lpm.2012.01.004

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

Review 1.  Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future.

Authors:  Wenkang Wang; Chuanjie Xu; Xinglong Ma; Xiaoming Zhang; Peng Xie
Journal:  Front Med (Lausanne)       Date:  2020-11-23

2.  Acute Painful Reversible Steroid Myopathy with IV Methylprednisolone.

Authors:  Boby Varkey Maramattom; Hanna Angel Meleth
Journal:  Ann Indian Acad Neurol       Date:  2020-04-28       Impact factor: 1.383

Review 3.  Management issues with exogenous steroid therapy.

Authors:  Hiren Patt; Tushar Bandgar; Anurag Lila; Nalini Shah
Journal:  Indian J Endocrinol Metab       Date:  2013-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.